Clinical Trial Update: A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4) [Phase 2]

View source ↗

Summary

Phase 2b study results for boceprevir in patients coinfected with HIV and hepatitis C, reporting safety and efficacy data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Boceprevir (boceprevir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV Infections, Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2013-08-30